[1]
“N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues”, Braz. J. Pharm. Sci., vol. 55, p. e18087, Dec. 2019, doi: 10.1590/s2175-97902019000218087.